BRCA1 and BRCA2 Genetic Testing
JH · Effective Dec 1, 2016
14 active Medicare policies list Z17.1, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Dec 1, 2016
JL · Effective Dec 1, 2016
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
3 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of Z17.1 |
|---|---|---|
| Tumor Markers | Mar 5, 2024 | Covered |
| Policy | Effective | Status of Z17.1 |
|---|---|---|
| Concert Genetic Testing Oncology: Algorithmic Assays | Not recorded | Referenced |
| Policy | Effective | Status of Z17.1 |
|---|---|---|
| Outpatient Alpha-Fetoprotein Testing | Apr 15, 2026 | Covered |
JL · Effective Oct 1, 2025
National · Effective Jan 1, 2022
National · Effective Nov 22, 2023
National · Effective Feb 19, 2026
J5 · Effective Jan 1, 2026